RAFAEL ANDRÉS
DEL ORBE BARRETO
Investigador hasta 2022
Hospital de Cruces
Barakaldo, EspañaPublicaciones en colaboración con investigadores/as de Hospital de Cruces (11)
2024
-
ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy
Blood, Vol. 143, Núm. 18, pp. 1807-1815
-
Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification
British Journal of Haematology, Vol. 204, Núm. 4, pp. 1529-1535
2023
-
Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes
HemaSphere, Vol. 7, Núm. 10, pp. E961
2022
-
Clinical management of the acute complications of sickle cell anemia: 11 years of experience in a tertiary hospital
Anales de Pediatria, Vol. 97, Núm. 1, pp. 4-11
-
Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea
Cancer, Vol. 128, Núm. 13, pp. 2441-2448
-
Southeast Asian ovalocytosis
Medicina Clinica, Vol. 159, Núm. 7, pp. 347-348
2021
-
Consensus document for the diagnosis and treatment of pyruvate kinase deficiency
Medicina Clinica, Vol. 157, Núm. 5, pp. 253.e1-253.e8
2016
-
Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation
Immunobiology, Vol. 221, Núm. 1, pp. 40-47
-
Detection of new pathogenic mutations in patients with congenital haemolytic anaemia using next-generation sequencing
International Journal of Laboratory Hematology, Vol. 38, Núm. 6, pp. 629-638
-
Hereditary xerocytosis, a misleading anemia
Annals of Hematology
-
Severe neonatal jaundice due to a de novo glucose-6-phosphate dehydrogenase deficient mutation
International Journal of Laboratory Hematology